A clinical trial co-led by Yale Urology showed high resolution micro-ultrasound is an effective tool for guiding prostate ...

Opens in a new tab or window Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

A new international study has shown that a new imaging method called micro-ultrasound (microUS) is just as effective as MRI ...

Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an ...

A trial tested MRI and microultrasonography guided biopsy separately and in combination for the detection of clinically significant prostate cancer.

High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively ...

"We're passionate about this research: finding drivers of disparities," Dr. El Khoury says, adding that the hope is to enhance access to MRI and potentially improve prostate cancer outcomes.

In a new study, researchers at Thomas Jefferson University combed through one of the largest cancer databases to assess the use of MRI in diagnosing prostate cancer from 2012 - 2019 and whether this ...

Shotmedia – stock.adobe.com In contrast, the new saliva tests analyze DNA, looking for a range of small genetic changes linked to prostate cancer. Trials show this approach is more effective ...